Insmed Affirms FY2026 Sales Guidance of $1.450B-$1.470B vs $1.699B Est

Benzinga Newsdesk www.benzinga.com Negative 67.2%

Neg 67.2% Neu 0% Pos 0%

Insmed (NASDAQ:INSM) affirms FY2026 sales outlook from $1.450 billion-$1.470 billion to $1.450 billion-$1.470 billion vs $1.699 billion estimate.